Skeletal Fluorosis-Induced Morphological Changes of the Temporomandi bular Joint and Associated Functional Limitations among Adults in Ethiopia

Heron Gezahegn*

School of Global Health and Bioethics, Euclid University, Banjul, Gambia

^*Corresponding Author: Heron Gezahegn, School of Global Health and Bioethics, Euclid University, Banjul, Gambia.

Received: 22 February 2023; Accepted: 13 March 2023; Published: 16 March 2023

Abbreviations:

ROM: Range of Motion; TMJ: Temporomandibular Joint; OPG: Orthopantomogram; IRB: Institutional Review Board; SPSS: Statistical Package for the Social Sciences

1. Introduction

Long-term and excessive fluoride consumption leads to impaired bone homeostasis and several chronic systemic diseases, including dental and skeletal fluorosis. Dental fluorosis, first described by Trendley Dean in 1937, is caused by excessive fluoride intake, which leads to multiple changes in developing tooth enamel and alters its structure [1,2]. Similarly, skeletal fluorosis is caused by toxic osteopathy characterized by massive fluoride incorporation into the bones [3]. The main pathological features of skeletal fluorosis include joint pain, stiffness, muscle weakness, and skeletal deformities [4,5]. Fluoride directly affects bone through two main mechanisms [6]. In mineralized tissues, fluoride is incorporated into apatite crystals by ion exchange, forming fluorapatite [7]. Such transformation leads to changes in crystallinity and decreased mechanical properties [8]. In bioactive tissue, fluoride also stimulates osteoblasts and osteocytes in a concentration-dependent mechanism [5].

The severity of skeletal fluorosis has been reported to range from mild joint pain to crippling disability and severe bone deformity [9]. Typical signs and symptoms include pain, limited joint motion, knock knees, leg flexion, and spinal curvature [10]. Recurrent joint pain, axial osteosclerosis, radiculomyelopathy, myelopathy, and joint stiffness are typical musculoskeletal problems associated with the disease [11]. Skeletal fluorosis may be completely asymptomatic in the early stages, and the only method to detect it earlier is a radiographic examination [12]. Most cases of skeletal fluorosis are diagnosed based on epidemiological data associated with radiographic findings [13]. However, skeletal fluorosis is not clinically noticeable and may be confused with other rheumatologic diseases [14]. Radiological changes can be seen in earlier stages of the disease, with irregular thickening and high density of bone on radiographic examination [15]. Radiographic presentation is mainly characterized by bone changes with osteocondensation and later ossification of many ligaments and interosseous membranes [16]. Accordingly, characteristic imaging features include osteosclerosis, osteophytosis, and ligamentous calcifications, primarily in the pelvis and spine [17]. Trabecular blurring or opacities, calcification or ossification of tendon attachments or muscles, hypertrophic ruts at bone margins with areas of relative radiolucency, and a coarse trabecular pattern [1,18].

In general, skeletal fluorosis can lead to significant and crippling deformities, including kyphosis, restricted spinal and thoracic motion, and deformities of the extraspinal joints, especially the hips, which are prone to hip osteoarthritis [18]. In addition, several studies reported a high incidence of genu valgum deformities [19]. Neurologic complications may also occur in 10% of patients diagnosed with skeletal fluorosis [20]. These are primarily due to mechanical compression of the spinal cord and nerve roots resulting from osteophytosis, gross reduction in the anteroposterior diameter of the spinal canal and intervertebral foramina, sclerosed spine, and ossified ligaments [21]. Myelopathy due to ossification of the posterior longitudinal ligament and/or ligamentum flavum has also been reported in patients with skeletal fluorosis, usually localized to the lower thoracic portion of the spinal cord [22]. Progressive radiculomyelopathy of fluorosis is characterized by muscle atrophy, atrophy, and spastic paraparesis or quadriparesis, often in flexion and fasciculation. Urinary incontinence, flexion spasms, and signs of long tract involvement have also been reported [23].

Although the most pronounced changes are seen in the spine, the orofacial skeletal tissues are not free from the adverse effects of skeletal fluorosis [18]. Cranial nerve palsies can occur due to skeletal fluorosis, usually the eighth nerve, with progressive high-frequency perceptual hearing loss due to nerve compression in the sclerosed auditory canal [1,15]. There are also reports of skeletal fluorosis-induced morphological changes in the jaw bones and temporomandibular joints [4]. However, there is limited data on skeletal fluorosis's effects on the T.M.J. [10]. This study was initiated to identify possible skeletal fluorosis-related temporomandibular joint morphological changes and associated functional limitations in adults in the Rift Valley region of Ethiopia.

2. Methodology

This study aimed to determine possible skeletal fluorosis-related morphologic T.M.J. changes and associated functional limitations in Ethiopian adults diagnosed with skeletal fluorosis. Accordingly, the methodology section focuses on the study's primary objective.

2.1 Research Design

A one point cross-sectional study was conducted to identify possible skeletal fluorosis-induced morphologic T.M.J. changes and associated functional limitations in adults diagnosed with skeletal fluorosis.

2.2 Study period and sample

The study was conducted between February 4, 2023, and March 20, 2023, in Addis Ababa, Ethiopia. Study participants diagnosed with skeletal fluorosis were included in this study. The diagnosis was based on epidemiological, clinical, biological, and radiological examination results.

2.3 Method and instruments of data collection

The relevant radiological data were collected after ethical approval by the Addis Ababa Health Department. Further radiological examinations were performed to rule out possible skeletal fluorosis-related morphological changes of the temporomandibular joints in the study participants. The jaw R.O.M. scale of TheraBite was used to assess the R.O.M. of the temporomandibular joint by measuring the distance between the maxillary and mandibular cutting edges (interincisal open distance) when the mouth was opened.

2.4 T.M.J. Assessment

Measurement of temporomandibular joint R.O.M., evaluation of temporomandibular joint sounds, and radiographic examination of the temporomandibular joint were considered relevant to assessing the temporomandibular joint. The physical examination focused primarily on determining the mobility and sounds of the T.M.J.

2.5 Evaluation of the jaw range of motion

Interincisal open measurement.

2.6 T.M.J. Noise Investigations

Auscultation of temporomandibular joint sounds with the stethoscope.

2.7 Radiologic orofacial assessment

A two-dimensional panoramic radiograph or orthopantomogram was used to rule out possible skeletal fluorosis-related morphologic changes in the temporomandibular joint. A bilateral radiographic examination of the temporomandibular joints was performed on each subject who participated in the study. An independent radiologist interpreted the radiographs. The range of motion of the temporomandibular joint was assessed to rule out potential functional limitations. In addition, the temporomandibular joint was examined with a stethoscope for possible sounds. It should be noted that differential diagnoses such as myelofibrosis, osteoblastic metastases, renal osteodystrophy, ankylosing spondylitis, and Paget's disease were considered to avoid confusion of findings.

2.8 Data management, analysis, and evaluation

 The IBM SPSS (Statistical Package for Social Sciences) Statistics, version 29 version was used to analyze the collected data. Descriptive statistical analysis was applied to describe and present the findings of the study in simple and compact forms.

2.9 Ethical considerations

Ethical assurance (approval number: A/A/H/8415/227) was provided by the Addis Ababa Health Bureau Institutional Review Board (I.R.B.), the ethics committee, after a review of the submitted study proposal. Study participants were adequately informed of the nature of the research project. In addition, verbal informed consent was obtained from each volunteer participant. The right of study participants to make decisions about themselves was respected. They were also free to interrupt or discontinue the study. The radiographs of the study participants and their respective interpretations were kept confidential.

2.10 Findings

Initially, 42 study participants were screened epidemiologically, biologically, clinically, and radiographically to be diagnosed with skeletal fluorosis. Of these, 9 were found to present skeletal fluorosis. Those 9 patients (three women and six men) underwent further radiographic investigation (O.P.G.) to rule out possible skeletal fluorosis-related morphological changes of the temporomandibular joint. The age of the study participants ranged from 41 to 69 years (Table 1). Various morphologic changes (n=11) were seen on the radiographs of the 8 study participants (3 females and five males). Three study participants (1 female and two males) had two morphologic changes each (bilateral skeletal fluorosis-induced T.M.J. lesions). The remaining 5 study participants had a single skeletal fluorosis-induced T.M.J. lesion. In general, ossification of various joint structures, osteophytosis, osteophytes, and hyperostosis was noted as skeletal fluorosis-related morphologic changes in the T.M.J.s. In addition, 6 study participants were found to have varying degrees of temporomandibular joint ankylosis (limitation of temporomandibular joint mobility). Of these, 4 participants exhibited low-intensity crepitus sounds on auscultation with a stethoscope (Table 2).

Table 1: Skeletal fluorosis-induced morphological changes of the temporomandibular joints.

Table 2: Skeletal fluorosis cases with different levels of mouth opening status (NOITULP grade).

3. Discussion

Fluoride is strongly associated with hard tissues in humans [24]. The chronic toxic effects of fluoride on the skeletal system were described in 1937 in the Indian state of Madras [25]. Skeletal fluorosis is a slowly progressive disease [26]. Clinical symptoms do not appear for decades and mainly affect the musculoskeletal system [27]. Patients with skeletal fluorosis often present with symptoms of varying degrees, primarily involving muscles, joints, nerve roots, intra-articular tissues, and bones [28]. Typical symptoms include vague joint pain, weakened muscles, stiffness of joints, muscle contractures, numbness, paresthesias, narrowing of the joint interior, and various types of bone deformities [22]. Some claim that the bones and joints of the upper and lower extremities, the muscles and nerve roots of the upper and lower extremities, and the spinal cord are the central anatomical regions affected by skeletal fluorosis [18]. However, several studies have described, albeit to a limited extent, the consequences of skeletal fluorosis on the oro-craniofacial anatomic complex, including the temporomandibular joint [4,6].

The temporomandibular joint is a joint with an articular head (both a hinge and a gliding joint) that harmonizes with various structures such as the bilateral mandibular condyle, meniscus, glenoid fossa, articular ligaments, and associated musculature [25,29]. Temporomandibular disorders (TMD) represent a group of conditions that cause pain or dysfunction in the temporomandibular joint and the muscles that control its movement [4]. Several studies have found that approximately 50-75% of the population is affected to some degree and shows signs of TMD [30]. Several RISK factors, including skeletal fluorosis, have been reported to promote the development of TMD [4,31].

Asawa et al. [4] studied the association of T.M.J. signs and symptoms with dental fluorosis and skeletal manifestations among residents of Dad, Bokersal, and Deotalab villages in Dungarpur district, Rajasthan, India. Analysis of the study revealed a significant association between signs and symptoms of T.M.J. and skeletal fluorosis. Cracking was the most prominent symptom (21.4%) suggestive of T.M.J. disorder in patients diagnosed with skeletal fluorosis. A study by Harbrow et al. [6] examined the effects of chronic fluoride administration on rat condylar cartilage. Based on morphometric and histochemical techniques, this study showed changes in the cartilaginous layer of the rat temporomandibular condyle after chronic exposure to fluoride (100 parts per million sodium fluoride in drinking water).

Similarly, in this study, morphological changes caused by skeletal fluorosis were observed in 11 of 16 temporomandibular joints examined.. The morphologic changes seen on the radiographs of the 8 study participants were ossification of various joint structures, osteophytosis, osteophytosis, osteophytes, and hyperostosis. In addition, 6 study participants had varying degrees of temporomandibular joint ankylosis. Of these, 4 participants exhibited low-intensity crepitus sounds on auscultation with a stethoscope.

4. Conclusion

Fluoride in various chemical forms, doses, and exposures has physicochemical and biological effects on cells and tissues. Long-term fluoride exposure can alter the function, differentiation, and proliferation of osteoblasts, osteoclasts, and chondrocytes and lead to skeletal fluorosis by disrupting the balance between bone formation and resorption. Such physiological disruption leads to morphological changes in bones and various joints, including T.M.J. In this study, the morphological changes caused by skeletal fluorosis and the associated functional limitations in 11 temporomandibular joints were described. Significant functional impairments were reported, which could potentially by roughened and irregular articular surfaces of the temporomandibular joints. Therefore, clinicians must consider skeletal fluorosis when examining and treating patients with T.M.J. symptoms. At the same time, in addition to ensuring a preventive strategy against fluorosis, it is essential to thoroughly investigate the complex pathogenesis of skeletal fluorosis and explore new targeted therapies at the molecular level to treat the disease effectively.

Conflict of Interest

The author declares no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

References

1. Sellami M, Riahi H, Maatallah K, et al. Skeletal fluorosis: don't miss the diagnosis! Skeletal Radiol 49 (2020): 345-357.
2. Gebretsadik HG. The severity of dental fluorosis among 12-15-year-old school children in Zeway, Oromia region, Ethiopia. Orapuh Journal 2 (2021): 1-9.
3. Almakadma AH, Almustanyir S, Aldalbahi H, et al. A case of fluorosis: fluoride-induced osteopetrosis. Cureus 13 (2021): 1-10.
4. Asawa K, Singh A, Bhat N, et al. Association of Temporomandibular Joint Signs and Symptoms with Dental Fluorosis and Skeletal Manifestations in Endemic Fluoride Areas of Dungarpur District, Rajasthan, India. Journal of Clinical and Diagnostic Research 9 (2015): ZC18-ZC21.
5. Du C, Xiao P, Gao S, et al. High fluoride intake impairs fracture healing by attenuating M2 macrophage differentiation. Frontiers in Bioengineering and Biotechnology 10(2022): 1-13.
6. Harbrow DJ, Robinson MG, Monsour PA. The effect of chronic fluoride administration on rat condylar cartilage. Australian Dental Journal 37 (1992): 55-62.
7. Liu XL, Song J, Liu KJ, et al. The role of inhibition of osteogenesis function by Sema4D/Plexin-B1 signaling pathway in skeletal fluorosis in vitro. J Huazhong Univ Sci Technolog Med Sci 35 (2015): 712-715.
8. Liang C. Evaluation of the effects of water defluoridation measures in China. Research Group Evaluation on the Effects of Water Defluoridation Measures in China. Wei Sheng Yan Jiu 27 (1998): 16-28.
9. Grandjean P. Thomsen G. Reversibility of skeletal fluorosis. Br J Ind Med 40 (1983): 456-461.
10. Kurland ES, Schulman RC, Zerwekh JE, et al. Recovery from skeletal fluorosis (a puzzling American case). Journal of Bone and Mineral Research 22 (2007): 163-170.
11. Newbrun E. What we know and don't know about fluoride. J Public Health Dent 70 (2010): 227-233.
12. Mosha HJ. Endemic dental fluorosis and the potential for defluoridation and fluoridation of water supplies in Tanzania. Odontostomatol Trop 7 (1984): 89-96.
13. Davies TC. Health effects of volcanism in the East African Rift. Environ Geochem Health 30(2008): 325-338.
14. EIu O, Chashchin MV, Zibarev EV. Characteristics of occupational fluorosis progression. Med Tr Prom Ecol 12 (2004): 27-29.
15. Gupta N, Gupta N, Chhabra P. Image diagnosis: dental and skeletal fluorosis. Perm J 20 (2016): e105-e106.
16. Mithal A, Trivedi N, Gupta SK, et al. The radiological spectrum of endemic fluorosis: relationship to calcium uptake. Skeletal Radiol 22 (1993): 257-261.
17. Reddy KVS, Mudumba VS, Tokala IM, et al. Ossification of the posterior longitudinal ligament and fluorosis. Neurol India 66 (2018): 1394-1399.
18. Saraux A, Bouillin D, Jeandel P, et al. Epidemiology of bone fluorosis of hydrotelluric origin. Rev Rhum Ed Fr 61 (1994): 847-851.
19. Shangguan C, Wang W, Sun J. A study on the value of vitamin C in the treatment of skeletal fluorosis. Zhonghua Nei Ke Za Zhi 34 (1995): 761-763.
20. Reddy DR, Prasad VS, Reddy JJ, et al. Neuro-radiology of skeletal fluorosis. Ann Acad Med Singap 22 (1993): 493-500.
21. Reddy DR. Neurology of endemic skeletal fluorosis. Neurol India 57 (2009): 7-12.
22. Tamboli BL, Mathur GM. Clinical criteria for screening skeletal fluorosis in an endemic area. Indian J Public Health 26 (1982): 244-250.
23. Walvekar SV, Qureshi BA. Endemic fluorosis and partial defluoridation of water supply-a public health problem in Kenya. Community Dent Oral Epidemiol 10 (1982): 156-160.
24. Wang F, Li Y, Tang D, et al. Effects of water enhancement and defluoridation on fluorosis-endemic areas in China: A meta-analysis. Environ Pollut 270 (2021): 116227.
25. Peter S. Essentials of Preventive and Community Dentistry. 2^nd Arya Publishing House, New Delhi (2004).
26. Warren JJ, Levy SM. Systemic fluoride. Sources, amounts, and effects of ingestion. Dent Clin North Am 43 (1999): 695-711.
27. Zhu C, Bai G, Liu X, et al. Screening of drinking water with high fluoride and arsenic content and investigation of endemic fluorosis and arsenism in Shaanxi Province, western China. Water Res 40 (2006): 3015-3022.
28. Yuan L, Fei W, Jia F, et al. Health risk in children from fluoride exposure in a typical endemic fluorosis area on the Loess Plateau, northern China, over the past decade. Chemosphere 243 (2020): 125451.
29. Hegde S, Mahadev R, Ganpathy KS, et al. Prevalence of signs and symptoms of temporomandibular disorder in dental students. Journal of Indian Academy of Oral Medicine and Radiology 23 (2011): 316-319.
30. Ryalat S, Baqain ZH, Amin WM, et al. Prevalence of temporomandibular joint disorders in the university of Jordan students. J Clin Med Res 1 (2009): 158-164.
31. Büyükkaplan US, Aksoy A, Kömerik N, et al. No significant association between temporomandibular joint disorders and dental fluorosis in Isparta, Turkey. Fluoride 45 (2012): 274-80.